MethylGene To Present At IBC Life Sciences’s 11th Annual World Congress-Drug Discovery Technology & Development

MethylGene Inc. (TSX: MYG) today announced that A. Robert MacLeod, Executive Director of Pharmacology and Cell Biology of MethylGene, will present at IBC’s 11th Annual World Congress in Boston on Wednesday, August 9th at 4:45 p.m. EDT.

MORE ON THIS TOPIC